These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 28611011)
1. Application of Plasma Genotyping Technologies in Non-Small Cell Lung Cancer: A Practical Review. Sacher AG; Komatsubara KM; Oxnard GR J Thorac Oncol; 2017 Sep; 12(9):1344-1356. PubMed ID: 28611011 [TBL] [Abstract][Full Text] [Related]
2. Plasma Cell-Free DNA Genotyping: From an Emerging Concept to a Standard-of-Care Tool in Metastatic Non-Small Cell Lung Cancer. Gray J; Thompson JC; Carpenter EL; Elkhouly E; Aggarwal C Oncologist; 2021 Oct; 26(10):e1812-e1821. PubMed ID: 34216176 [TBL] [Abstract][Full Text] [Related]
3. Fundamental Concepts in the Application of Plasma Genotyping (Liquid Biopsy) to Sacher AG JCO Precis Oncol; 2018 Nov; 2():1-12. PubMed ID: 35135113 [TBL] [Abstract][Full Text] [Related]
4. Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer. Sacher AG; Paweletz C; Dahlberg SE; Alden RS; O'Connell A; Feeney N; Mach SL; Jänne PA; Oxnard GR JAMA Oncol; 2016 Aug; 2(8):1014-22. PubMed ID: 27055085 [TBL] [Abstract][Full Text] [Related]
5. Bias-Corrected Targeted Next-Generation Sequencing for Rapid, Multiplexed Detection of Actionable Alterations in Cell-Free DNA from Advanced Lung Cancer Patients. Paweletz CP; Sacher AG; Raymond CK; Alden RS; O'Connell A; Mach SL; Kuang Y; Gandhi L; Kirschmeier P; English JM; Lim LP; Jänne PA; Oxnard GR Clin Cancer Res; 2016 Feb; 22(4):915-22. PubMed ID: 26459174 [TBL] [Abstract][Full Text] [Related]
6. Detection of the T790M mutation of EGFR in plasma of advanced non-small cell lung cancer patients with acquired resistance to tyrosine kinase inhibitors (West Japan oncology group 8014LTR study). Takahama T; Sakai K; Takeda M; Azuma K; Hida T; Hirabayashi M; Oguri T; Tanaka H; Ebi N; Sawa T; Bessho A; Tachihara M; Akamatsu H; Bandoh S; Himeji D; Ohira T; Shimokawa M; Nakanishi Y; Nakagawa K; Nishio K Oncotarget; 2016 Sep; 7(36):58492-58499. PubMed ID: 27542267 [TBL] [Abstract][Full Text] [Related]
7. Circulating Tumor DNA as a Liquid Biopsy: Current Clinical Applications and Future Directions. Komatsubara KM; Sacher AG Oncology (Williston Park); 2017 Aug; 31(8):618-27. PubMed ID: 28812303 [TBL] [Abstract][Full Text] [Related]
8. EGFR mutational genotyping of liquid based cytology samples obtained via fine needle aspiration (FNA) at endobronchial ultrasound of non-small cell lung cancer (NSCLC). Reynolds JP; Tubbs RR; Minca EC; MacNamara S; Almeida FA; Ma PC; Pennell NA; Cicenia JC Lung Cancer; 2014 Nov; 86(2):158-63. PubMed ID: 25263855 [TBL] [Abstract][Full Text] [Related]
9. Biopsy-free circulating tumor DNA assay identifies actionable mutations in lung cancer. Villaflor V; Won B; Nagy R; Banks K; Lanman RB; Talasaz A; Salgia R Oncotarget; 2016 Oct; 7(41):66880-66891. PubMed ID: 27602770 [TBL] [Abstract][Full Text] [Related]
10. Association Between Younger Age and Targetable Genomic Alterations and Prognosis in Non-Small-Cell Lung Cancer. Sacher AG; Dahlberg SE; Heng J; Mach S; Jänne PA; Oxnard GR JAMA Oncol; 2016 Mar; 2(3):313-20. PubMed ID: 26720421 [TBL] [Abstract][Full Text] [Related]
11. Digital PCR analysis of plasma cell-free DNA for non-invasive detection of drug resistance mechanisms in EGFR mutant NSCLC: Correlation with paired tumor samples. Ishii H; Azuma K; Sakai K; Kawahara A; Yamada K; Tokito T; Okamoto I; Nishio K; Hoshino T Oncotarget; 2015 Oct; 6(31):30850-8. PubMed ID: 26334838 [TBL] [Abstract][Full Text] [Related]
12. Sensitive genotyping of somatic mutations in the EGFR, KRAS, PIK3CA, BRAF genes from NSCLC patients using hydrogel biochips. Emelyanova M; Arkhipova K; Mazurenko N; Chudinov A; Demidova I; Zborovskaya I; Lyubchenko L; Zasedatelev A; Nasedkina T Appl Immunohistochem Mol Morphol; 2015 Apr; 23(4):255-65. PubMed ID: 25153497 [TBL] [Abstract][Full Text] [Related]
13. A Highly Sensitive and Quantitative Test Platform for Detection of NSCLC EGFR Mutations in Urine and Plasma. Reckamp KL; Melnikova VO; Karlovich C; Sequist LV; Camidge DR; Wakelee H; Perol M; Oxnard GR; Kosco K; Croucher P; Samuelsz E; Vibat CR; Guerrero S; Geis J; Berz D; Mann E; Matheny S; Rolfe L; Raponi M; Erlander MG; Gadgeel S J Thorac Oncol; 2016 Oct; 11(10):1690-700. PubMed ID: 27468937 [TBL] [Abstract][Full Text] [Related]
14. EGFR mutations in lung cancer: from tissue testing to liquid biopsy. Fenizia F; De Luca A; Pasquale R; Sacco A; Forgione L; Lambiase M; Iannaccone A; Chicchinelli N; Franco R; Rossi A; Morabito A; Rocco G; Piccirillo MC; Normanno N Future Oncol; 2015; 11(11):1611-23. PubMed ID: 26043215 [TBL] [Abstract][Full Text] [Related]
15. A comparative study of EGFR oncogenic mutations in matching tissue and plasma samples from patients with advanced non-small cell lung carcinoma. Chai X; Ren P; Wei B; Ma J; Mai L; Cram DS; Song Y; Guo Y Clin Chim Acta; 2016 Jun; 457():106-11. PubMed ID: 27071701 [TBL] [Abstract][Full Text] [Related]
16. A Prospective Evaluation of Circulating Tumor Cells and Cell-Free DNA in EGFR-Mutant Non-Small Cell Lung Cancer Patients Treated with Erlotinib on a Phase II Trial. Yanagita M; Redig AJ; Paweletz CP; Dahlberg SE; O'Connell A; Feeney N; Taibi M; Boucher D; Oxnard GR; Johnson BE; Costa DB; Jackman DM; Jänne PA Clin Cancer Res; 2016 Dec; 22(24):6010-6020. PubMed ID: 27281561 [TBL] [Abstract][Full Text] [Related]
17. Cell-Free DNA in Oncology: Gearing up for Clinic. Ulrich BC; Paweletz CP Ann Lab Med; 2018 Jan; 38(1):1-8. PubMed ID: 29071812 [TBL] [Abstract][Full Text] [Related]
18. Designing a definitive trial for adjuvant targeted therapy in genotype defined lung cancer: the ALCHEMIST trials. Alden RS; Mandrekar SJ; Oxnard GR Chin Clin Oncol; 2015 Sep; 4(3):37. PubMed ID: 26408304 [TBL] [Abstract][Full Text] [Related]
19. Development and clinical validation of a circulating tumor DNA test for the identification of clinically actionable mutations in nonsmall cell lung cancer. Liu L; Liu H; Shao D; Liu Z; Wang J; Deng Q; Tang H; Yang H; Zhang Y; Qiu Y; Cui F; Tan M; Zhang P; Li Z; Liu J; Liang W; Wang Y; Peng Z; Wang J; Yang H; Mao M; Kristiansen K; Ye M; He J Genes Chromosomes Cancer; 2018 Apr; 57(4):211-220. PubMed ID: 29277949 [TBL] [Abstract][Full Text] [Related]
20. Comparison of plasma and tissue samples in epidermal growth factor receptor mutation by ARMS in advanced non-small cell lung cancer. Ma M; Shi C; Qian J; Teng J; Zhong H; Han B Gene; 2016 Oct; 591(1):58-64. PubMed ID: 27370697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]